Lodoco (Colchicine) Patent Expiration, LOE Window & CMS Spending

Lodoco (Colchicine) by Agepha Fz: FDA Orange Book LOE 2034-05-09, 12 AB generics, $606K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAgepha Fz
FDA Application & PathwayN215727 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2034-05-09
Orange Book Patents (*PED Extensions)13 patents (0 *PED)
Active AB-Rated Generic Competitors12
2024 CMS Total Public Spend$606K
2024 Medicare Part D Spend$606K
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel